Suzanne J. SUCHARD

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 12,012,452
- Issue date Jun 18, 2024
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating systemic lupus erythematosus using a domain ant...
- Patent number 11,912,769
- Issue date Feb 27, 2024
- Bristol-Myers Squibb Company
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Predictive peripheral blood biomarker for checkpoint inhibitors
- Patent number 11,899,017
- Issue date Feb 13, 2024
- Bristol-Myers Squibb Company
- Nataly Manjarrez Orduño
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acids encoding antagonistic CD40 monoclonal antibodies
- Patent number 11,613,585
- Issue date Mar 28, 2023
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating autoimmune disease using a domain antibody dire...
- Patent number 11,466,091
- Issue date Oct 11, 2022
- Bristol-Myers Squibb Company
- Marek Honczarenko
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating systemic lupus erythematosus using a domain ant...
- Patent number 11,267,888
- Issue date Mar 8, 2022
- Bristol-Myers Squibb Company
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40...
- Patent number 11,220,550
- Issue date Jan 11, 2022
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 11,180,567
- Issue date Nov 23, 2021
- Bristol-Myers Squibb Company
- Steven G. Nadler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating immune diseases by administering antibody polyp...
- Patent number 11,136,406
- Issue date Oct 5, 2021
- Bristol-Myers Squibb Company
- Anish Suri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 10,919,965
- Issue date Feb 16, 2021
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding antibody polypeptides that antagonize CD40
- Patent number 10,544,228
- Issue date Jan 28, 2020
- Bristol-Myers Squibb Company
- Anish Suri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of using antibody polypeptides that antagonize CD40 to treat...
- Patent number 10,435,475
- Issue date Oct 8, 2019
- Bristol-Myers Squibb Company
- Marek Honczarenko
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating immune diseases by administering antibody polyp...
- Patent number 10,196,451
- Issue date Feb 5, 2019
- Bristol-Myers Squibb Company
- Steven G. Nadler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 9,908,937
- Issue date Mar 6, 2018
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 9,765,150
- Issue date Sep 19, 2017
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40
- Patent number 9,475,879
- Issue date Oct 25, 2016
- Bristol-Myers Squibb Company
- Anish Suri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 9,228,018
- Issue date Jan 5, 2016
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 9,085,629
- Issue date Jul 21, 2015
- Bristol-Myers Squibb Company
- Murray McKinnon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding antibody polypeptides that antagonize CD40L
- Patent number 8,981,072
- Issue date Mar 17, 2015
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 8,895,010
- Issue date Nov 25, 2014
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 8,454,959
- Issue date Jun 4, 2013
- Bristol-Meyers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 8,168,759
- Issue date May 1, 2012
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human phosphatase RET31, and variants thereof
- Patent number 7,358,074
- Issue date Apr 15, 2008
- Bristol-Myers Squibb Company
- Donald G. Jackson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polynucleotides encoding the novel human phosphatase, RET31, and va...
- Patent number 7,153,678
- Issue date Dec 26, 2006
- Bristol-Myers Squibb
- Donald G. Jackson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cd45 inhibitors
- Patent number 6,939,896
- Issue date Sep 6, 2005
- Astrazeneca AB
- Marc Jerome Chapdelaine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PREDICTIVE PERIPHERAL BLOOD BIOMARKER FOR CHECKPOINT INHIBITORS
- Publication number 20240241129
- Publication date Jul 18, 2024
- Bristol-Myers Squibb Company
- Nataly MANJARREZ ORDUÑO
- G01 - MEASURING TESTING
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20230322941
- Publication date Oct 12, 2023
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRE...
- Publication number 20230295321
- Publication date Sep 21, 2023
- Bristol-Myers Squibb Company
- Marek HONCZARENKO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20220177596
- Publication date Jun 9, 2022
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...
- Publication number 20220144951
- Publication date May 12, 2022
- Bristol-Myers Squibb Company
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20220073636
- Publication date Mar 10, 2022
- Bristol-Myers Squibb Company
- Steven G. NADLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREDICTIVE PERIPHERAL BLOOD BIOMARKER FOR CHECKPOINT INHIBITORS
- Publication number 20210123920
- Publication date Apr 29, 2021
- Bristol-Myers Squibb Company
- Nataly MANJARREZ ORDUÑO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20210047414
- Publication date Feb 18, 2021
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...
- Publication number 20200247890
- Publication date Aug 6, 2020
- Bristol-Myers Squibb Company
- Xavier Valencia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRE...
- Publication number 20200216552
- Publication date Jul 9, 2020
- Bristol-Myers Squibb Company
- Marek HONCZARENKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLY...
- Publication number 20200199244
- Publication date Jun 25, 2020
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THER...
- Publication number 20200148779
- Publication date May 14, 2020
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20190100595
- Publication date Apr 4, 2019
- Bristol-Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF
- Publication number 20180340031
- Publication date Nov 29, 2018
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20180142023
- Publication date May 24, 2018
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20180051091
- Publication date Feb 22, 2018
- Bristol-Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRE...
- Publication number 20170306034
- Publication date Oct 26, 2017
- Bristol-Myers Squibb Company
- Marek HONCZARENKO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40
- Publication number 20170015754
- Publication date Jan 19, 2017
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF USING ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40 TO TREAT...
- Publication number 20160355596
- Publication date Dec 8, 2016
- Bristol-Myers Squibb Company
- Marek HONCZARENKO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20160075790
- Publication date Mar 17, 2016
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20150299321
- Publication date Oct 22, 2015
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20150023976
- Publication date Jan 22, 2015
- Bristol -Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20140099707
- Publication date Apr 10, 2014
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40
- Publication number 20140099317
- Publication date Apr 10, 2014
- DOMANTIS LIMITED
- Anish Suri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20130109846
- Publication date May 2, 2013
- Domantis Ltd.
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20130095109
- Publication date Apr 18, 2013
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20120201814
- Publication date Aug 9, 2012
- Domantis Ltd.
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20100028354
- Publication date Feb 4, 2010
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human phosphatase RET31, and variants thereof
- Publication number 20060014180
- Publication date Jan 19, 2006
- Donald G. Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYNUCLEOTIDES ENCODING NOVEL HUMAN PHOSPHATASES
- Publication number 20050130286
- Publication date Jun 16, 2005
- Donald G. Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Suzanne J. SUCHARD

Person

Patents Grantslast 30 patents

Compositions monovalent for CD28 binding and methods of use

Methods of treating systemic lupus erythematosus using a domain ant...

Predictive peripheral blood biomarker for checkpoint inhibitors

Nucleic acids encoding antagonistic CD40 monoclonal antibodies

Methods of treating autoimmune disease using a domain antibody dire...

Methods of treating systemic lupus erythematosus using a domain ant...

Antagonistic anti-CD40 antibodies and methods of antagonizing CD40...

Antibody polypeptides that antagonize CD40L

Methods of treating immune diseases by administering antibody polyp...

Compositions monovalent for CD28 binding and methods of use

Nucleic acids encoding antibody polypeptides that antagonize CD40

Method of using antibody polypeptides that antagonize CD40 to treat...

Methods of treating immune diseases by administering antibody polyp...

Compositions monovalent for CD28 binding and methods of use

Antibody polypeptides that antagonize CD40L

Antibody polypeptides that antagonize CD40

Antibody polypeptides that antagonize CD40L

Compositions monovalent for CD28 binding and methods of use

Nucleic acids encoding antibody polypeptides that antagonize CD40L

Antibody polypeptides that antagonize CD40L

Compositions monovalent for CD28 binding and methods of use

Compositions monovalent for CD28 binding and methods of use

Human phosphatase RET31, and variants thereof

Polynucleotides encoding the novel human phosphatase, RET31, and va...

Cd45 inhibitors

Patents Applicationslast 30 patents

PREDICTIVE PERIPHERAL BLOOD BIOMARKER FOR CHECKPOINT INHIBITORS

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRE...

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

PREDICTIVE PERIPHERAL BLOOD BIOMARKER FOR CHECKPOINT INHIBITORS

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...

METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRE...

METHODS OF TREATING IMMUNE DISEASES BY ADMINISTERING ANTIBODY POLY...

MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THER...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRE...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40

METHOD OF USING ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40 TO TREAT...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

Human phosphatase RET31, and variants thereof

POLYNUCLEOTIDES ENCODING NOVEL HUMAN PHOSPHATASES